|
|
Article: ORTEC SUCCESSFULY DEFENDS EUROPEAN PATENT ON ORCEL.
- Article from:
- Worldwide Biotech
- Article date:
- May 1, 2002
CopyrightCOPYRIGHT 2002 Worldwide Videotex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Ortec International (Nasdaq:ORTC), New York, has successfully defended an opposition filed with the European Patent Office by Advanced Tissue Sciences, Inc. challenging the validity of Ortec's European patent on OrCel(TM), Ortec's tissue engineering platform technology.
Commenting on the successful defense, Steven Katz, Ph.D., Ortec's chairman and CEO stated, "This is the second challenge from a competitor Ortec has successfully defended. We have always felt confident in the strength of our patent, and the European Patent Office's decision reaffirms the novelty and inventiveness of Ortec's leading technology." Advanced Tissue Sciences has the right to appeal for ...